Heptamidine dimethanesulfonate
Heptamidine dimethanesulfonate is a potent S100B inhibitor (Kd 6.9 μM) derived from Pentamidine, showing selective cytotoxicity against S100B-overexpressing melanoma cells. It is also utilized as a research tool in studies of Myotonic Dystrophy (DM), applicable in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
161374-55-6
Product Name Alternative
Cell, dystrophy, cancer, Calcium-Binding, calcium-binding protein S100B, inhibit, Myotonic, Inhibitor, Heptamidine, Heptamidine dimethanesulfonate, HeLa, melanoma, S100B, SBi4211, SBi-4211, SBi4211 dimethanesulfonate, SBi 4211
Purity
97.80% (May vary between batches)
Solubility
H2O:8.33 mg/mL (14.86 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.57 mM) ; DMSO:70 mg/mL (124.85 mM)
Smiles
CS (O) (=O) =O.CS (O) (=O) =O.NC (=N) c1ccc (OCCCCCCCOc2ccc (cc2) C (N) =N) cc1
Molecular Formula
C23H36N4O8S2
Molecular Weight
560.68
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A02660-2-APC 100 µg/Vial
Anti-Serine racemase/SRR Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details 
